news might be hitting next week. fingers crossed

Knsc hope this news comes soon. Take all us shareholders to the promise land!

expanding is the number one sign of good things to come!

SILA properties include Keeno Strike project in Clark County, Nevada and Guadalupe project located in Zacatecas State, Mexico . In addition, SILA latest project is the option agreement it signed earlier this month to acquire a 100 percent interest in the 439.8-acre high-grade silver-gold La Escondida Project located in Sonora State, Mexico.

expanding +1

sila

$1.00 without a doubt

sila sums it up


Gold American Mining Corp. (SILA) Stock Review: The $100 Million Shell Company

SILA Youtube growth

SILA, - Gold American Mining Corp. - CRWESelect.com Stock To Watch!

SILA recently entered into a $7.5 million equity financing agreement with a European institutional investment group that specializes in backing precious metals and mining ventures. SILA reported they received funds in the amount of $300,000 in virtue of this agreement and that SILA still has a balance of $7.2 million that SILA could call upon

SILA


1st phase on its way...




the project’s exploratory work program will test ~1.1 million ounces of gold and ~69.0 million ounces of silver potential, which would be accessible via open-pit bulk handling methods unavailable to the industry at the time these properties were initially developed.

weve hit gold in mexico! SILA

"We are excited to begin exploration operations at La Escondida, at a time when Gold American is seeking to find new silver-gold deposits. The project has an exciting potential, the infrastructure in place is excellent and multiple exploration targets have already been identified

Great news!!!!!

Gold American Mining Corp. (OTC.BB:SILA - News) ("Gold American" and/or "the Company") is pleased to report that its Board of Directors has approved the initiation of the first phase of field operations at its La Escondida Project in Sonora State, Mexico.

First Alert News- SILA “Initiate Field Operations at La Escondida Project”
Posted on September 13, 2010 by admin


Gold American Mining Corp.

(OTCBB: SILA)

Gold American Mining has a lot in the works that should soon be released to investors. Continue to closely follow out coverage and investment in Gold American Mining for significant news. Harold



Read more: http://thestockmarketwatch.com/newsletters/2010/09/13/first-alert-news-sila-initiate-field-operations-at-la-escondida-project/#ixzz0zTEpFpvf

both. the company strives in the long run to help as many problems the word throws at them

time to buy.. collect all the info here and invest in solid numbers

In 2006, global sales of the AD drugs were worth some US$ 1.6 billion. The Alzheimer’s drugs are relatively expensive medicines (costing around $1,700 to $2,300 per year for the patient). They can cause side effects however and these outweigh the sometimes limited benefits and lead to the end of the treatment. Thus, a new drug or strategy such as the one that INSA has developed with no side effects and good benefits would be a real advantage to the patient. "

def going to be number 1 today that is all im going to say about this anymore

Spencer Pharmaceutical Inc. (SPPH), is a newly founded public company and is our newest trade alert looking to kick off the week on a profitable note.

(SPPH), is a US based Pharmaceutical Research and Development Corporation, which is developing innovative drug release and absorption systems for the treatment of metabolic diseases such as diabetes and metabolic syndrome.


Read more: http://stockreads.com/Stock-Newsletter.aspx?id=31735#ixzz0y5pVstul

"The Strategy:
The past few years, the scientific team has been dedicated to prove the concept and has claimed the intellectual property through a registered patent. The therapeutic challenges being the same for all Central Nervous System (CNS) diseases, INSA has created a series of prodrugs able to cross efficiently the Blood Brain Barrier and outclass all the current commercial drugs for CNS diseases. (Alzheimer’s, depression, Schizophrenia, bipolar disorder and brain tumours).

Its all about the team of spph

"The Scienfitic Team
Controlled release systems have been developed through a partnership from a very experienced team at UQAM with the intention of reducing or eliminating the side effects of many drugs, potentiate their biological activity as well as providing the possibility for once-a-day administration

technology people!!!

The technology is based on patented natural polymers used as a vehicle to deliver active compounds at the absorption sites without compromising their stability and bio-availability . To be effective, it is necessary to prepare the polymer in order to confer specific deliver-abilities and protection of the active compound capabilies

for this reason alone spph will continue to grow

i think im sold anyone else

"Having both Dr. Mircea Mateescu (announced June 15, 2010) and Dr. Canh on the Spencer Pharmaceutical advisory board and leading the Company's research goals are all positives in our collective efforts to successfully commercialize our technologies. We warmly welcome Dr. Canh," stated Mr. Ian Morrice, EVP and Director of Spencer Pharmaceutical Inc. Furthermore, "Although we originally targeted Diabetes, our proprietary technology also applies to the multibillion dollar generic drug market," reiterated Mr. Morrice.

BOSTON, MA--(Marketwire - August 30, 2010) - Spencer Pharmaceutical Inc. (PINKSHEETS: =SPPH">SPPH) announces the appointment of Dr. Le Tien Canh, PhD to its Scientific Advisory Board.

Dr. Canh brings a diversified field of research knowledge to the team. He has been leading the research team at the University of Quebec at Montreal (UQAM) in the development of its Diabetes (Metformin), "Controlled Release Delivery System."

you should buy spph because of the increase since monday. with all the alerts and posts im def going to be buying some shares

Growth of over 130% in the past several weeks.

It is currently trading at 35 cents per share, which is extremely undervalued compared to its 1 year top price figure of over $1.

Has been on an uptrend for the past few weeks, rising in share price of over 130%.

Increase in price per share on Friday over 9%

Rapidly increasing volume of over 5x which shows fast investor interest in this company.

Float levels of less than 46 million shares.

Estimated market capital of over $90 million

Growing Pharmaceutical Industry which offers hundreds of billions of dollars in profits for companies in this industry.

The company that we are alerting for Monday August 30, 2010 is

EMERGENSYS CORP (SPPH.PK)

Since we broke through resistance on SPPH at the $0.25 level, we've been marching slowly, but steadily higher. Closing at $0.35 on Friday, we're now up a very respectable 75% since we alerted our readers to the name, but we think there could still be substantial upside remaining as more and more investors come around the SPPH story. Today we got another press release from SPPH which tells us that there are some serious scientific minds behind the company.

Have you heard???


Over the last week SPPH has increased over 100% in share price on growing volume. Being that the volume isn't through the roof it is obvious SPPH is still flying under the radar.

However, we believe that SPPH's time to shine has arrived.

SPPH has acquired 15 years of extensive research, accelerating our path to commercialization.

rise up spph


1) First, SPPH's technology allows for less painful drug administration, and significantly increases the time over which drugs cab be absorbed into the body, offering more effective treatment.

2) Second, SPPH's technology for drug delivery can be applied to all kinds of prescription drugs out there, and with the drug delivery industry forecasted to reach $80.2 billion in the US by 2012 (as per the The Freedonia Group) the potential market for SPPH's products is ENORMOUS!

The application possibilities for SPPH's drug delivery technology are nearly endless, and that?s why we are so excited about the story. Even with the recent 50% run, we think there could still be significant upside left in the stock, especially if a major decided to wise up and take out the competition!

spph benefits video



http://www.itsallbull.net/iabtv.php?id=360

hear it first!!!!



SPPH had another AMAZING day yesterday as we rallied another 20% to close at $0.30. Our readers are now up a whopping 50% from our initial mention of SPPH when it was trading $0.20. Congrats goes out to all those who jumped in and are now sitting pretty on top of some tidy profits! Volume was light in yesterday?s session, but we think that will change when investors get wind of today's PR.

In 2006, global sales of the AD drugs were worth some US$ 1.6 billion. The Alzheimer’s drugs are relatively expensive medicines (costing around $1,700 to $2,300 per year for the patient). They can cause side effects however and these outweigh the sometimes limited benefits and lead to the end of the treatment. Thus, a new drug or strategy such as the one that INSA has developed with no side effects and good benefits would be a real advantage to the patient. "
INSA’s strategy could be applied for AD but also for so many other diseases having an important part in the pharmaceutical market